Glazener C M, Evans J H
Health Services Research Unit (Flea), University of Aberdeen, Foresterhill Lea, Foresterhill, Aberdeen, Scotland, UK, AB25 2ZD.
Cochrane Database Syst Rev. 2001(1):CD002911. doi: 10.1002/14651858.CD002911.
Enuresis (bedwetting) is a socially disruptive and stressful condition which affects around 15-20% of five year olds, and up to 2% of young adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological costs to the children can be great.
To assess the effects of alarm interventions on nocturnal enuresis in children, and to compare alarms with other interventions.
The following electronic databases were searched: MEDLINE to June 1997; AMED; ASSIA; BIDS; BIOSIS Previews (1985-1996); CINAHL; DHSS Data; EMBASE (1974 to June 1997); PsycLIT and SIGLE. Organisations, manufacturers, researchers and health professionals concerned with enuresis were contacted for information. The reference sections of obtained studies were also checked for further trials. Date of the most recent search: July 1997.
All randomised trials of alarm interventions for nocturnal enuresis in children were included in the review. Trials were eligible for inclusion if: children were randomised to alarm treatment compared with controls, other behavioural methods or drugs for nocturnal bedwetting; participants with organic causes for their bedwetting were excluded; and baseline assessments of the level of bedwetting were reported. Trials focused solely on daytime wetting were excluded.
Two reviewers independently assessed the quality of the eligible trials, and extracted data.
Twenty two randomised trials met the inclusion criteria, involving 1125 children who received treatment with alarms. The quality of many of the trials was poor, and many comparisons were addressed only by single trials. Children treated with alarms were significantly more likely than untreated controls to become dry during treatment (RR for failing to achieve 14 dry nights 0.27, 95% CI 0.19 to 0.39) and failing to remain dry (RR 0.58, 95%CI 0.46 to 0.74). There was insufficient evidence to judge whether one type of alarm is better than another and whether alarms alone were as good as or better than other behavioural interventions alone or as a supplement to alarm treatment. Desmopressin or tricyclics seem as effective as alarms while on treatment. There was limited evidence to suggest that the relapse rate might be lower after stopping alarm treatment than after desmopressin (RR 0.11, 95% CI 0.02 to 0.78).
REVIEWER'S CONCLUSIONS: Alarm interventions are an effective treatment for nocturnal bedwetting in children. Desmopressin and tricyclics appeared as effective while on treatment, but this effect was not sustained after treatment stopped, and alarms may be more effective in the long term. Comparisons between drug and behavioural treatments are needed, and should include relapse rates after treatment is finished.
遗尿症(尿床)是一种会对社会造成干扰且带来压力的状况,影响着约15%至20%的五岁儿童,以及高达2%的年轻人。尽管自发缓解率较高,但对儿童造成的社会、情感和心理代价可能很大。
评估警报干预对儿童夜间遗尿症的效果,并将警报与其他干预措施进行比较。
检索了以下电子数据库:截至1997年6月的MEDLINE;AMED;ASSIA;BIDS;BIOSIS Previews(1985 - 1996年);CINAHL;卫生与社会保障部数据;EMBASE(1974年至1997年6月);PsycLIT和SIGLE。联系了与遗尿症相关的组织、制造商、研究人员和健康专业人士以获取信息。还检查了所获研究的参考文献部分以查找更多试验。最近一次检索日期:1997年7月。
本综述纳入了所有针对儿童夜间遗尿症的警报干预随机试验。若试验符合以下条件则有资格纳入:将儿童随机分配至警报治疗组,并与对照组、其他行为方法或治疗夜间尿床的药物进行比较;排除有尿床器质性原因的参与者;报告尿床水平的基线评估。仅关注白天尿床的试验被排除。
两名评审员独立评估符合条件的试验质量,并提取数据。
22项随机试验符合纳入标准,涉及1125名接受警报治疗的儿童。许多试验质量较差,许多比较仅由单个试验进行。接受警报治疗的儿童在治疗期间比未治疗的对照组更有可能不再尿床(未能达到14个干爽夜晚的相对危险度为0.27,95%可信区间为0.19至0.39),且不太可能再次尿床(相对危险度为0.58,95%可信区间为0.46至0.74)。没有足够证据判断一种警报是否比另一种更好,以及单独使用警报是否与单独使用其他行为干预措施一样有效或更好,或者作为警报治疗的补充是否更好。去氨加压素或三环类药物在治疗期间似乎与警报一样有效。有有限证据表明,停止警报治疗后的复发率可能低于停止去氨加压素治疗后的复发率(相对危险度为0.11,95%可信区间为0.02至0.78)。
警报干预是治疗儿童夜间尿床的有效方法。去氨加压素和三环类药物在治疗期间似乎同样有效,但治疗停止后这种效果未持续,从长期来看警报可能更有效。需要对药物治疗和行为治疗进行比较,且应包括治疗结束后的复发率。